Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

DexCom promotes Sayer to CEO

This article was originally published in Clinica

Executive Summary

Glucose monitoring firm DexCom has tapped its president and COO Kevin Sayer to be president and CEO. Mr Sayer succeeds Terry Gregg, who is transitioning to the role of executive chair after three years in the top spot and seven years of service with DexCom. Mr Sayer, who became the firm’s president and COO in January 2013 after working as president for two years, has served as a board member since November 2007. Prior to this he was chief financial officer of Biosensors International, a medtech company specializing in interventional cardiology and critical care procedures. DexCom competes with Medtronic in the continuous glucose monitor (CGM) market. In October, it gained the first FDA approval for a CGM that can wirelessly transmit data to a smartphone via a cradle. And in December its technology was approved for use with Johnson & Johnson/Animas’s Vibe insulin pump.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT102251

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel